×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NPCE – neuropace, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NPCE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/14
02:10 pm
npce
NeuroPace (NASDAQ:NPCE) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
NeuroPace (NASDAQ:NPCE) had its "buy" rating reaffirmed by analysts at UBS Group AG.
1/13
07:42 am
npce
NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook [Yahoo! Finance]
Medium
Report
NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook [Yahoo! Finance]
1/13
07:41 am
npce
NeuroPace sees Q4 revenue of about $26.6M [Seeking Alpha]
Medium
Report
NeuroPace sees Q4 revenue of about $26.6M [Seeking Alpha]
1/13
07:30 am
npce
NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook
Medium
Report
NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook
12/31
09:27 am
npce
NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/31
09:00 am
npce
NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/17
08:00 am
npce
NeuroPace Files PMA Supplement to FDA Seeking Expanded RNS® System Indication for Idiopathic Generalized Epilepsy
Medium
Report
NeuroPace Files PMA Supplement to FDA Seeking Expanded RNS® System Indication for Idiopathic Generalized Epilepsy
12/16
09:32 am
npce
NeuroPace (NASDAQ:NPCE) had its price target raised by analysts at UBS Group AG from $18.00 to $22.00. They now have a "buy" rating on the stock.
Low
Report
NeuroPace (NASDAQ:NPCE) had its price target raised by analysts at UBS Group AG from $18.00 to $22.00. They now have a "buy" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/23
04:16 pm
npce
Form 4 NeuroPace Inc For: Dec 19 Filed by: LACOB JOSEPH
Low
Report
Form 4 NeuroPace Inc For: Dec 19 Filed by: LACOB JOSEPH
12/23
04:16 pm
npce
Form 4 NeuroPace Inc For: Dec 19 Filed by: Kumar Rakhi
Low
Report
Form 4 NeuroPace Inc For: Dec 19 Filed by: Kumar Rakhi
12/23
04:15 pm
npce
Form 4 NeuroPace Inc For: Dec 19 Filed by: Geiger Uri
Low
Report
Form 4 NeuroPace Inc For: Dec 19 Filed by: Geiger Uri
12/23
04:15 pm
npce
Form 4 NeuroPace Inc For: Dec 19 Filed by: Fischer Frank M
Low
Report
Form 4 NeuroPace Inc For: Dec 19 Filed by: Fischer Frank M
12/15
04:27 pm
npce
Form 144 NeuroPace Inc Filed by: Morrell Martha
Low
Report
Form 144 NeuroPace Inc Filed by: Morrell Martha
12/4
04:30 pm
npce
Form 4 NeuroPace Inc For: Dec 03 Filed by: Morrell Martha
Medium
Report
Form 4 NeuroPace Inc For: Dec 03 Filed by: Morrell Martha
12/1
04:15 pm
npce
Form 4 NeuroPace Inc For: Nov 27 Filed by: Becker Joel
Low
Report
Form 4 NeuroPace Inc For: Nov 27 Filed by: Becker Joel
12/1
04:15 pm
npce
Form 4 NeuroPace Inc For: Nov 27 Filed by: Morrell Martha
Low
Report
Form 4 NeuroPace Inc For: Nov 27 Filed by: Morrell Martha
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: